|
Immunotherapy
Citations 231-240 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
- Nicolaus Kröger, Avichai Shimoni, Maria Zagrivnaja, Francis Ayuk, Michael Lioznov, Heike Schieder, Helmut Renges, Boris Fehse, Tatjana Zabelina, Arnon Nagler, and Axel R. Zander
Blood 2004; 104: 3361-3363.
[Abstract]
[Full text]
[PDF]
From the bench to the bedside: ways to improve rituximab efficacy
- Guillaume Cartron, Hervé Watier, Josée Golay, and Philippe Solal-Celigny
Blood 2004; 104: 2635-2642.
[Abstract]
[Full text]
[PDF]
Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens
- Yucheng Tang, Lixin Zhang, Jing Yuan, Hakan Akbulut, Jonathan Maynard, Phyllis-Jean Linton, and Albert Deisseroth
Blood 2004; 104: 2704-2713.
[Abstract]
[Full text]
[PDF]
Manipulating dendritic cell biology for the active immunotherapy of cancer
- David W. O'Neill, Sylvia Adams, and Nina Bhardwaj
Blood 2004; 104: 2235-2246.
[Abstract]
[Full text]
[PDF]
Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma
- Hannes Kaufmann, Markus Raderer, Stefan Wöhrer, Andreas Püspök, Alexander Bankier, Christoph Zielinski, Andreas Chott, and Johannes Drach
Blood 2004; 104: 2269-2271.
[Abstract]
[Full text]
[PDF]
Targeted delivery of adenoviral vectors by cytotoxic T cells
- Patricia Yotnda, Barbara Savoldo, Nicolas Charlet-Berguerand, Cliona Rooney, and Malcolm Brenner
Blood 2004; 104: 2272-2280.
[Abstract]
[Full text]
[PDF]
Targeted deletion of T-cell clones using alpha-emitting suicide MHC tetramers
- Rui Rong Yuan, Phillip Wong, Michael R. McDevitt, Ekaterina Doubrovina, Ingrid Leiner, William Bornmann, Richard O'Reilly, Eric G. Pamer, and David A. Scheinberg
Blood 2004; 104: 2397-2402.
[Abstract]
[Full text]
[PDF]
Human CD62L– memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion
- Aaron E. Foster, Marina Marangolo, Mary M. Sartor, Stephen I. Alexander, Min Hu, Kenneth F. Bradstock, and David J. Gottlieb
Blood 2004; 104: 2403-2409.
[Abstract]
[Full text]
[PDF]
A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells
- Mark S. Cragg, Mike B. Bayne, Alison L. Tutt, Ruth R. French, Stephen Beers, Martin J. Glennie, and Timothy M. Illidge
Blood 2004; 104: 2540-2542.
[Abstract]
[Full text]
[PDF]
Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome
- M. Louise Markert, Marilyn J. Alexieff, Jie Li, Marcella Sarzotti, Daniel A. Ozaki, Blythe H. Devlin, Debra A. Sedlak, Gregory D. Sempowski, Laura P. Hale, Henry E. Rice, Samuel M. Mahaffey, and Michael A. Skinner
Blood 2004; 104: 2574-2581.
[Abstract]
[Full text]
[PDF]
|
|
